|
 |
| |
Staff Bio
Shiela M. Strauss, Ph.D.
Affiliation
New York University College of Nursing
Education
Ph.D., Educational Psychology, Graduate School and University Center of the City University of New York
Research Interests - Ways to support primary and secondary prevention of HCV and HIV in drug users and other at risk persons
- Drug treatment program organizational response to infectious diseases (especially HCV)
- Application of optimal statistical methodology for data analysis (especially involving multilevel modeling and missing data).
Awards and Memberships - Ad Hoc Peer Reviewer, Behavioral and Social Science Approaches to Preventing HIV/AIDS (BSPH), Center for Scientific Review, National Institutes of Health
- Dissertation Year Fellowship Award, Graduate School and University Center of the City University of New York, 1996
- Edyth May Sliffe Award for Distinguished High School Mathematics Teaching, Mathematics Association of America, 1989
- Presidential Scholars Program Certificate of Excellence, The White House, 1988
- Fulbright Senior Specialist Award, 2005
Academic Appointments - Associate Professor & Co-Director, Statistics and Data Management Core, NYU Colleges of Dentistry and Nursing
|
|
Cohen-Moreno, R., Schiff, M., Levitt, S., Bar-Hamburger, R., Strauss, S., & Neumark, Y. (2010). Knowledge about hepatitis-C among methadone maintenance treatment patients in Israel. Substance Use and Misuse, 45 (1-2), 58-76.
|
|
Strauss, S. M., Russell, S., Wheeler, A., Norman, R., Borrell, L. N., & Rindskopf, D. (2010). The dental office visit as a potential opportunity for diabetes screening: An analysis using NHANES 2003-2004 data. Journal of Public Health Dentistry, 70, 156-162.
|
|
Lelutiu-Weinberger, C., Pouget, E. R., Des Jarlais, D., Cooper, H. L., Scheinmann, R., Stern, R., Strauss, S. M., & Hagan, H. (2009). A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Social Science and Medicine, 68 (3), 579-590.
|
|
Strauss, S. M., & Rindskopf, D. M. (2009). Screening patients in busy hospital-based HIV care centers for hazardous and harmful drinking patterns: The identification of an optimal screening tool. Journal of the International Association of Physicians in AIDS Care, 8 (6), 347-353.
|
|
Strauss, S. M., Munoz-Plaza, C., Tiburcio, N. J., Maisto, S. A., Conigliaro, J., Gwadz, M., Lunievicz, J., & Norman, R. (2009). HIV care providers’ role legitimacy as supporters of their patients’ alcohol reduction. The Open Infectious Diseases Journal, 3 (13-20).
|
|
Strauss, S. M., Tiburcio, N. J., Munoz-Plaza, C., Gwadz, M., Lunievicz, J., Osborne, A., Padilla, D., McCarty-Arias, M., & Norman, R. (2009). HIV care providers' implementation of routine alcohol reduction support for their patients. AIDS Patient Care and STDs, 23 (3), 211-218.
|
|
Strauss, S. M., Wheeler, A. J., Russell, S. L., Brodsky, A., Davidson, R. M., Gluzman, R., Li, L., Malo, R. G., Salis, B., Schoor, R., & Tzvetkova, K. (2009). The potential use of gingival crevicular blood for measuring glucose to screen for diabetes: An examination based on characteristics of the blood collection site. Journal of Periodontology, 80 (6), 907-914.
|
|
Deren, S., Strauss, S., Kang, S. Y., Colon, H. M., & Robles, R. R. (2008). Sex risk behaviors of drug users: A dual site study of predictors over time. AIDS Education and Prevention, 20 (4), 325-337.
|
|
Munoz-Plaza, C. E., Strauss, S., Astone-Twerell, J., Des Jarlais, D., Gwadz, M., Hagan, H., Osborne, A., & Rosenblum, A. (2008). Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.. International Journal of Drug Policy, 19 (1), 71-78.
|
|
Stern, R. K., Hagan, H., Lelutiu-Weinberger, C., Des Jarlais, D., Scheinmann, R., Strauss, S., Pouget, E. R., & Flom, P. (2008). The HCV Synthesis Project: Scope, methodology, and preliminary results. BMC Medical Research Methodology, 8:62.
|
|
Strauss, S. M., Munoz-Plaza, C., Tiburcio, N. J., Astone-Twerell, J., Des Jarlais, D. C., Gwadz, M., Hagan, H., Osborne, A., & Rosenblum, A. (2008). Barriers and facilitators to undergoing hepatitis C virus (HCV) testing through drug treatment programs. Journal of Drug Issues, 38 (4), 1161-1185.
|
|
Gwadz, M. V., Nish, D., Leonard, N. R., & Strauss, S. M. (2007). Gender differences in traumatic events and rates of post-traumatic stress disorder among homeless youth. Journal of Adolescence, 30 (1), 117-129.
|
|
Hagan, H., Des Jarlais, D. C., Stern, R., Lelutiu-Weinberger, C., Scheinmann, R., Strauss, S., & Flom, P. L. (2007). HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy, 18 (5), 341-351.
|
|
Scheinmann, R., Hagan, H., Lelutiu-Weinberger, C., Stern, R., Des Jarlais, D. C., Flom, P. L., & Strauss, S. (2007). Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence, 89 (1), 1-12.
|
|
Strauss, S. M., Astone-Twerell, J. M., Munoz-Plaza, C., Des Jarlais, D. C., Gwadz, M., Hagan, H., Osborne, A., & Rosenblum, A. (2007). Correlates of drug treatment program staff's self efficacy to support their clients' hepatitis C virus (HCV) related needs. American Journal of Drug and Alcohol Abuse, 33 (2), 245-251.
|
|
Strauss, S. M., Astone-Twerell, J., Munoz-Plaza, C. E., Des Jarlais, D. C., Gwadz, M., Hagan, H., Osborne, A., & Rosenblum, A. (2007). Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Services Research, 7, 39.
|
|
Astone-Twerell, J. M., Strauss, S. M., Hagan, H., & Des Jarlais, D. C. (2006). Drug treatment programs’ HCV service delivery to their HCV positive clients. Addiction Research and Theory, 14 (3), 289-302.
|
|
Astone-Twerell, J., Strauss, S. M., & Munoz-Plaza, C. (2006). Stigma2: Hepatitis C and drug abuse. HCV Advocate - Medical Writers' Circle.
|
|
Munoz-Plaza, C. E., Strauss, S. M., Astone-Twerell, J., Des Jarlais, D. C., & Hagan, H. (2006). Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs. Journal of Psychoactive Drugs, 38 (3), 233-241.
|
|
Strauss, S. M., Astone-Twerell, J. M., Munoz-Plaza, C., Des Jarlais, D. C., Gwadz, M., Hagan, H., Osborne, A., & Rosenblum, A. (2006). Hepatitis C knowledge among staff in U.S. drug treatment programs. Journal of Drug Education, 36 (2), 141-158.
|
|
Strauss, S. M., Rindskopf, D. M., Astone-Twerell, J. M., Des Jarlais, D. C., & Hagan, H. (2006). Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the US. Drug and Alcohol Dependence, 83 (1), 15-24.
|
|
Astone, J. M., Strauss, S. M., Munoz-Plaza, C., Hagan, H., & Des Jarlais, D. C. (2005). Providing support to drug users infected with hepatitis C: The role of methadone maintenance treatment staff. Journal of Maintenance in the Addictions, 3 (1), 33-46.
|
|
Hagan, H., Strauss, S. M., Astone, J. M., & Des Jarlais, D. C. (2005). Medical examinations to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection. Clinical Infectious Diseases, 40 (Supplement 5), S297-S303.
|
|
Munoz-Plaza, C. E., Strauss, S. M., Astone, J. M., Des Jarlais, D. C., & Hagan, H. (2005). Hepatitis C service delivery in prisons: Peer education from the "Guys in Blue". Journal of Correctional Health Care, 11 (4), 347-368.
|
|
Munoz-Plaza, C. E., Strauss, S. M., Astone, J. M., Des Jarlais, D. C., & Hagan, H. (2005). HCV (hepatitis C virus) pre-test and post-test counseling services at drug treatment programs: Missed opportunities for primary prevention. Contemporary Drug Problems, 32 (4), 655-675.
|
|
Page(s)
|
| 1 2 3 |
|
| |
|
|
|
|